Description: Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Home Page: www.granulesindia.com
My Home Hub
Hyderabad,
500081
India
Phone:
91 40 3066 0000
Officers
| Name | Title |
|---|---|
| Mr. Sandip Neogi | Chief Financial Officer |
| Mr. Sivaram Prasad Guntamukkala | Chief Operating Officer |
| Ms. Chaitanya Tummala | Company Sec. & Compliance Officer |
| Mr. Atul Dhavle B.E. | Chief HR Officer & Head of Operational Excellence |
| Mr. Harsha Chigurupati | Exec. Director |
| Mr. M. Devendra Kumar | Sr. VP of API Manufacturing |
| Mr. Krishna Prasad Chigurupati | Chairman & MD |
| Mr. Sumanta Bajpayee | Head of Corp. Fin., Treasury & Investor Relations |
| Mr. P. S. N. Murthy | Sr. VP of HR |
| Mr. Desireddy Malikarjuna Reddy | Sr. VP of GPI |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 22.1198 |
| Price-to-Book MRQ: | 4.8877 |
| Price-to-Sales TTM: | 3.2998 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 3029 |